Testing Choices: From the standard to the extraordinary
Test | Test Name |
---|---|
0995U | Carbon Disulfide Exposure (TTCA), Urine |
1010B | Carbon Tetrachloride, Blood |
1055B | Celecoxib, Blood |
1055SP | Celecoxib, Serum/Plasma |
1110B | Chlorobenzene, Blood |
1110SP | Chlorobenzene, Serum/Plasma |
1111U | Chlorobenzene Exposure (p-Chlorophenol), Urine |
1130B | Chloroform, Blood |
1306U | Codeine - Total (Conjugated/Unconjugated) Screen, Urine |
1415B | Cyclosporine, Blood |
2423B | Comprehensive Volatiles Panel, Blood |
8661B | Codeine and Metabolite - Free (Unconjugated), Blood |
8661SP | Codeine and Metabolite - Free (Unconjugated), Serum/Plasma |
8661U | Codeine and Metabolite - Total (Conjugated/Unconjugated), Urine |
9145UC | Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |